Increased mortality in ICU patients ≥70 years old with COVID-19 compared to patients with other pneumonias.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
05 2023
Historique:
revised: 19 11 2022
received: 30 09 2022
accepted: 11 12 2022
medline: 12 5 2023
pubmed: 9 2 2023
entrez: 8 2 2023
Statut: ppublish

Résumé

Patients over 70 years old represent a substantial proportion of the COVID-19 ICU population and their mortality rates are high. The aim of this study is to describe the outcomes of patients ≥70 years old admitted to Dutch ICUs with COVID-19, compared to patients ≥70 years old admitted to the ICU for bacterial and other viral pneumonias, with adjustments for age, comorbidities, severity of illness, and ICU occupancy rate. Retrospective cohort study including patients ≥70 years old admitted to Dutch ICUs, comparing patients admitted with COVID-19 from March 1st 2020 to January 1st 2022 with patients ≥70 years old admitted because of a bacterial and other viral pneumonia, both divided in a historical (i.e., January 1st 2017 to January 1st 2020) and current cohort (i.e., March 1st 2020 to January 1st 2022). Primary outcome is hospital mortality. 11,525 unique patients ≥70 years old admitted to Dutch ICUs were included; 5094 with COVID-19, 5334 with a bacterial pneumonia, and 1312 with another viral pneumonia. ICU-mortality and in-hospital mortality rates of the patients ≥70 years old admitted with COVID-19 were 39.7% and 47.6% respectively. ICU- and hospital mortality rates of the patients who were admitted in the same or in an historical time period with a bacterial pneumonia or other viral pneumonias were considerably lower (19.5% and 28.6% for patients with a bacterial pneumonia in the historical cohort and 19.1% and 28.8% in the same period, for the patients with other viral pneumonias 20.7% and 28.9%, and 22.7% and 31.8% respectively, all p < 0.001). Differences persisted after correction for several clinical characteristics and ICU occupancy rate. In ICU-patients ≥70 years old, COVID-19 is more severe compared to bacterial or viral pneumonia.

Sections du résumé

BACKGROUND
Patients over 70 years old represent a substantial proportion of the COVID-19 ICU population and their mortality rates are high. The aim of this study is to describe the outcomes of patients ≥70 years old admitted to Dutch ICUs with COVID-19, compared to patients ≥70 years old admitted to the ICU for bacterial and other viral pneumonias, with adjustments for age, comorbidities, severity of illness, and ICU occupancy rate.
METHODS
Retrospective cohort study including patients ≥70 years old admitted to Dutch ICUs, comparing patients admitted with COVID-19 from March 1st 2020 to January 1st 2022 with patients ≥70 years old admitted because of a bacterial and other viral pneumonia, both divided in a historical (i.e., January 1st 2017 to January 1st 2020) and current cohort (i.e., March 1st 2020 to January 1st 2022). Primary outcome is hospital mortality.
RESULTS
11,525 unique patients ≥70 years old admitted to Dutch ICUs were included; 5094 with COVID-19, 5334 with a bacterial pneumonia, and 1312 with another viral pneumonia. ICU-mortality and in-hospital mortality rates of the patients ≥70 years old admitted with COVID-19 were 39.7% and 47.6% respectively. ICU- and hospital mortality rates of the patients who were admitted in the same or in an historical time period with a bacterial pneumonia or other viral pneumonias were considerably lower (19.5% and 28.6% for patients with a bacterial pneumonia in the historical cohort and 19.1% and 28.8% in the same period, for the patients with other viral pneumonias 20.7% and 28.9%, and 22.7% and 31.8% respectively, all p < 0.001). Differences persisted after correction for several clinical characteristics and ICU occupancy rate.
CONCLUSIONS
In ICU-patients ≥70 years old, COVID-19 is more severe compared to bacterial or viral pneumonia.

Identifiants

pubmed: 36751883
doi: 10.1111/jgs.18220
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1440-1451

Informations de copyright

© 2023 The American Geriatrics Society.

Références

Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157-160.
World Health Organization: WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2022 Jun 17] Available from: https://covid19.who.int
Worldometer COVID-19. https://www.worldometers.info/coronavirus
Phua J, Weng L, Ling L, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020;8:506-517.
Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65:101205.
Henkens MTHM, Raafs AG, Verdonschot JAJ, et al. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study. BMC Geriatr. 2022;22:184.
CDC: Risk for COVID-19 Infection, Hospitalization, and Death By Age Group.
CDC: Demographic Trends of COVID-19 cases and deaths in the US reported to CDC [Internet]. Available from: https://covid.cdc.gov/covid-data-tracker/#demographics
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430-436.
Jung C, Flaatten H, Fjølner J, et al. The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study. Crit Care. 2021;25:149.
Gao Z, Xu Y, Sun C, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54:12-16.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782-793.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323:1574-1581.
Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81:e16-e25.
van de Klundert N, Holman R, Dongelmans DA, de Keizer NF. Data resource profile: the Dutch National Intensive Care Evaluation (NICE) registry of admissions to adult intensive care units. Int J Epidemiol. 2015;44:1850-1850h.
Dutch National Intensive Care Evaluation (NICE) registry. [Internet]. Available from: http://www.stichting-nice.nl
Zimmerman JE, Kramer AA, McNair DS, et al. Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med. 2006;34:1297-1310.
Dongelmans DA, Termorshuizen F, Brinkman S, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in The Netherlands. Ann Intensive Care. 2022;12:5.
Brinkman S, Termorshuizen F, Dongelmans DA, et al. Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs. J Crit Care. 2022;68:76-82.
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11:29.
Mendes A, Serratrice C, Herrmann FR, et al. Predictors of In-hospital mortality in older patients with COVID-19: the COVIDAge study. J Am Med Dir Assoc. 2020;21:1546-1554.e3.
Fang X, Li S, Yu H, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020;12:12493-12503.
Földi M, Farkas N, Kiss S, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis. Obes Rev. 2020;21:e13095.
Hussain A, Mahawar K, Xia Z, Yang W, el-Hasani S. Obesity and mortality of COVID-19. Meta-analysis. Obes Res Clin Pract. 2020;14:295-300.
Dana R, Bannay A, Bourst P, et al. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes. 2021;45:2028-2037.
Kooistra EJ, Brinkman S, van der Voort PHJ, et al. Body mass index and mortality in coronavirus disease 2019 and other diseases: a cohort study in 35,506 ICU patients. Crit Care Med. 2022;50:e1-e10.
Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL. Adult ICU triage during the coronavirus disease 2019 pandemic: who will live and who will die? Recommendations to improve survival. Crit Care Med. 2020;48:1196-1202.
Haas LEM, de Lange DW, van Dijk D, van Delden JJM. Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19. Crit Care. 2020;24:321.
Guidet B, Jung C, Flaatten H, et al. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med. 2022;48:435-447.
Boumendil A, Aegerter P, Guidet B, the CUB-Rea Network. Treatment intensity and outcome of patients aged 80 and older in intensive care units: a multicenter matched-cohort study. J Am Geriatr Soc. 2005;53:88-93.
Jung C, Flaatten H, de Lange D, Beil M, Guidet B. The relationship between treatment limitations and pressure on intensive care units in elderly patients. Intensive Care Med. 2022;48:124-125.
Guidet B, Flaatten H, Boumendil A, et al. Withholding or withdrawing of life-sustaining therapy in older adults (≥80 years) admitted to the intensive care unit. [internet]. Intensive Care Med. 2018;44:1027-1038[cited 2019 Jan 23]. doi:10.1007/s00134-018-5196-7
Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061-1066.
Philippart F, Vesin A, Bruel C, et al. The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments. Intensive Care Med. 2013;39:1565-1573.
Soliman IW, Leaver S, Flaatten H, et al. Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70 years. Age Ageing. 2022;51:1-10.

Auteurs

Lenneke E M Haas (LEM)

Department of Intensive Care Medicine, Diakonessenhuis, Utrecht, the Netherlands.

Fabian Termorshuizen (F)

Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands.
Amsterdam Public Health, Quality of Care & Methodology, Amsterdam, The Netherlands.
National Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.

Corstiaan A den Uil (CA)

Department of Intensive Care, Maasstad Hospital, Rotterdam, the Netherlands.

Nicolette F de Keizer (NF)

Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands.
Amsterdam Public Health, Quality of Care & Methodology, Amsterdam, The Netherlands.
National Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.

Dylan W de Lange (DW)

National Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands.
Department of Intensive Care Medicine, University Medical Center, Utrecht University, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH